Name: 2018 Joint Statistical Meetings
Start: 2018-07-28T07:00:00+00:00
End: 2018-08-02
Location: Vancouver Convention Centre

Keyword Search

Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme

Keyword Search Criteria: DR returned 191 record(s)

Sunday, 07/29/2018

Addressing Overfitting in Mixtures of Factor Analyzers
Jeffrey L Andrews, University of British Columbia Okanagan

Spatio-Temporal Analysis of Children and Adolescents' Emergency Department Use for Mental Health Reasons in Alberta, Canada
Michelle Thiessen, Simon Fraser University; Joan Hu, Simon Fraser University; Rhonda J. Rosychuk, University of Alberta

Statistical Methods for Addressing Missing Data in HIV/AIDS Surveillance Systems
Sahar Zangeneh, Fred Hutchinson Cancer Research Center; Ying Qing Chen, Fred Hutchinson Cancer Research Center; Deborah Donnell, Fred Hutch

Detection of Trend Onset in Environmental Time Series
Ying Zhang, Acadia University

Polynomial Based Approximate Probability Distributions
Chris Elrod, Baylor University; James Stamey, Baylor University

Regression Calibration to Address Error Prone Time-To-Event Outcomes
Eric Oh, University of Pennsylvania; Pamela A Shaw, University of Pennsylvania

Senior Swim Competition Times
David P. Doane, Oakland University; Lori E Seward, University of Colorado; Kevin Murphy, Oakland University
2:05 PM

Robust Dose Response Estimation
Shouhao Zhou, University of Texas MD Anderson Cancer Center
2:05 PM

Optimal AK Composite Estimators in Current Population Survey
Yang Cheng, US Census Bureau; Jun Shao, University of Wisconsin; Yu Zhou, East China Normal University
2:05 PM

Regression Calibration to Address Error Prone Time-To-Event Outcomes
Eric Oh, University of Pennsylvania; Pamela A Shaw, University of Pennsylvania
2:05 PM

MIDD: Perspectives and Possibilities
Dionne Price, Food and Drug Administration
2:05 PM

Polynomial Based Approximate Probability Distributions
Chris Elrod, Baylor University; James Stamey, Baylor University
2:10 PM

Statistical Development in Addressing Delayed Treatment Effect or Crossing Survival Curves in Immuno-Oncology Clinical Trials
Huyuan Yang, Takeda Oncology Pharmaceutical
2:20 PM

Graphical and Quantitative Literacy: Empowerment Begins with Naming and Describing What We Do
Susan Duke, FDA
2:45 PM

Preferential Recruitment Modeling for Respondent-Driven Sampling
Katherine McLaughlin, Oregon State University
2:50 PM

Nonparametric Empirical Bayes Methods for High Dimension Problems
Linda Zhao, University of Pennsylvania; Junhui Cai, University of Pennsylvania
2:55 PM

Leveraging Existing Information in Medical Device Clinical Trials
Rajesh Nair, CDRH/FDA; Xuefeng Li, CDRH/FDA; Laura Thompson, CDRH/FDA
3:05 PM

Leukemia and Myeloid Malignancy Among Cohorts of Persons Exposed to Low Dose (<100 mSv) of Ionizing Radiation in Childhood.
Mark P Little, National Cancer Institute; David Borrego, National Cancer Institute; Ben French, Radiation Effects Research Foundation; Lydia B Zablotska, University of California San Francisco; Jacob Adams, University of Rochester School of Medicine and Dentistry; Rodrigue Allodji, Equipe d'Epidémiologie des radiations, Unité 1018 INSERM; Florent de Vathaire, Equipe d'Epidémiologie des radiations, Unité 1018 INSERM; Choonsik Lee, National Cancer Institute; Alina V Brenner, Radiation Effects Research Foundation; Martha S Linet, National Cancer Institute; Marie Lundell, Karolinska University Hospital; Siegal Sadetzki, Gertner Institute for Epidemiology and Health Policy Research; Richard Wakeford, Centre for Occupational and Environmental Health, Institute of Population Health; Amy Berrington de Gonzalez, National Cancer Institute; Erik Holmberg, Sahlgrenska University Hospital; Mark Pearce, University of Newcastle upon Tyne, Sir James Spence Institute of Child Health; Michele M Doody, National Cancer Institute; Jeremy Miller, Information Management Services; David Campbell, Information Management Services
3:05 PM

Use of Real-World in Clinical Drug Development
Xiuyu Julie Cong, Boehringer Ingelheim Pharmaceuticals Inc; Susan Wang, Boehringer Ingelheim Pharmaceuticals Inc.
3:05 PM

Data-Driven Regularization and Priors in GWAS and Mediation Analysis
Sunduz Keles, University of Wisconsin, Madison
3:20 PM

Statistical Evaluation of Oncology Drug Trial Portfolios and the Potential for Inappropriate Regulatory Approval: a Simulation Study
Renee Gennarelli, Memorial Sloan Kettering Cancer Center; Peter Bach, Memorial Sloan Kettering Cancer Center; Mithat Gonen, Memorial Sloan Kettering Cancer Center
3:20 PM

A Case Study on Model Based Meta-Analysis (MBMA) for Drug Development Decisions
Guohui Liu, Takeda Pharmaceuticals Inc ; Zhaoyang Teng, Takeda pharmaceuticals international, Co; Zhaowei Hua, Takeda Pharmaceuticals International Co.; Neeraj Gupta, Takeda pharmaceuticals international, Co; Richard Labotka, Takeda pharmaceuticals international, Co
3:35 PM

Kaplan-Meier Based Methods to Address Non-Proportional Hazard Issues
Bo Huang, Pfizer Inc.
4:05 PM

Adjusting a Subject-Specific Timing of Event in Longitudinal Studies
Hyunkeun Cho, University of Iowa; Seonjin Kim, Miami University; Myunghee Lee, Weill Cornell Medical College
4:05 PM

DETECTING ADVERSE DRUG EFFECTS from PHARMACOVIGILANCE DATABASES
Yu Gao, University of Waterloo; Kun Liang, University of Waterloo
4:20 PM

Multivariate FDR Control for Omics Data Integration
Ali Shojaie, University of Washington; Kasra Alishahi, Sharif University of Technology; Ahmad Reza Ehyaee, Sharif University of Technology
4:25 PM

Effective Story Telling with Dynamic Data Visualizations
Ruth Hummel, SAS Institute, JMP Division; Mia Stephens, SAS Istitute, JMP Division
4:35 PM

Practical Bayesian Modeling and Subgroup Inference in Alzheimer's Drug Development
Brad Carlin, University of Minnesota; Patrick Schnell, Ohio State University; Mark Fiecas, University of Minnesota; Peter Müller, University of Texas Austin; Qi Tang, Sanofi; Walter Offen, AbbVie
5:05 PM

Risk Prediction Through Temporal Phenotyping and Incorporation of MedDRA Information
Yong Chen, University of Pennsylvania; Rui Duan, University of Pennsylvania
5:20 PM

Extendability for Exchangeable Network Models
Jiaqi Yin, University of Washington; Thomas Richardson, University of Washington
5:20 PM

Monday, 07/30/2018

Statistical Challenges in Developing Data-Driven Discovery, Diagnosis, and Treatment of Psychiatric Diseases
Thaddeus Tarpey, Wright State University

The Difference Two Data Points Can Make
Kirk Anderson, Grand Valley State University; Mary Richardson, Grand Valley State University

Evaluating Drug Combinations in the Discovery and Pre-Clinical Stage
Jocelyn Sendecki

A Computational, Data-Driven Approach to Game Theory
Michael Alexander Smith, Purdue University; Mark Daniel Ward, Purdue University; Deidra Coleman, Wofford College; Doug G Crabill, Purdue University; Jamylle Carter, Diablo College; Jennifer Travis, Lone Star College; Jack Henry Good, Purdue University; Bret Benesh, College of Saint Benedict and Saint John's University

A Joint Modeling Approach for Directed Acyclic Network Data
Yan Zhou, Merck &Co., Inc

Assessing Treatment Benefit in Patient-Centric Study Designs
Jagadish Gogate, Johnson & Johnson-Janssen R&D

Equipment Independent Estimation of Novel Metrics for Ranking Amateur Auto Racing Drivers
Alexandra Peterson; Daniel L. Gillen, University of California, Irvine; Hal Stern, University of California, Irvine

Spline Smoothing in Dendrochronology
Nicholas Bussberg, Indiana University; Justin Maxwell, Indiana University; Scott Robeson, Indiana University; Chunfeng Huang, Indiana University

Developing and Evaluating Methods for Estimating Race/Ethnicity in an Incomplete Dataset Using Address, Surname and Family Race
Gabriella Christine Silva, Brown University; Roee Gutman, Brown University

Addressing Time of Measurement Bias in Records of Daily Temperature Extrema: A Spatio-Temporal Imputation Strategy
Maxime Rischard, Harvard Statistics; Natesh Pillai, Harvard Statistics; Karen A. McKinnon, National Center for Atmospheric Research; Descartes Labs

Assessing Therapeutic Equivalence of Brand and Generic Drugs Using Observational Data
Lamar Hunt, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Daniel Scharfstein, Johns Hopkins University; Irene Murimi, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Jodi Segal, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Ravi Varadhan, Johns Hopkins University; Ramin Mojtabai, Johns Hopkins Bloomberg SPH

Nonparametric K-Sample Test on Riemannian Manifolds with Application to Analyzing Mitochondrial Shapes
Ruiyi Zhang, Florida State University; Todd Ogden, Columbia University; Martin Picard, Columbia University; Anuj Srivastava, Florida State University
8:35 AM

Sensory Attributes That Highly Distinguish Products Do Not Necessarily Drive Consumer Liking of the Said Products
Jason Parcon, PepsiCo
9:05 AM

Large Scale Application of Mendelian Randomization for Systematic Causal Inferences Using GWAS Summary Statistics for Drug Discovery and Development
Xing Chen, Pfizer Inc WRD
9:05 AM

Comparison of Event Rates Between On- and Off-Drug Treatment Periods for a Recurrent Adverse Event
Brenda Crowe, Eli Lilly & Co.; Haoda Fu, Eli Lilly and Company; Yebin Tao, Eli Lilly and Company
9:35 AM

Use of National Syndromic Surveillance Data to Monitor Weekly Lyme Disease Activity in Four US Regions
Hong Zhou, CDC; Michael Coletta, CDC; Howard Burkom, Johns Hopkins Applied Physics Laboratory; Aaron Kite Powell, CDC; Ruth Jajosky, CDC; Tara Strine, CDC
9:35 AM

Outer Node FDR Control for Gene Ontology and Other Directed Acyclic Graphs
Eugene Katsevich, Stanford University; Chiara Sabatti, Stanford University; Marina Bogomolov, Technion
9:35 AM

Pseduolikelihood for Clustered Time-To-Event Outcomes from Complex Surveys
Jing Wang
9:50 AM

Nonresponse Bias Analysis for National Survey on Drug Use and Health Using Small Area Estimation Methodology
Akhil Vaish, RTI International; Matthew Williams, SAMHSA/CBHSQ; Kathy Spagnola, RTI International; Ana Saravia, RTI International; Neeraja Sathe, RTI International
10:05 AM

ESTIMATING TREATMENT IMPORTANCE in MULTIDRUG-RESISTANT TUBERCULOSIS USING TARGETED LEARNING: AN OBSERVATIONAL INDIVIDUAL PATIENT DATA NETWORK META-ANALYSIS
Guanbo Wang, McGill University; Mireille Schnitzer, University of Montreal; Andrea Benedetti, Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre
10:35 AM

Joint Testing in High-Dimensional Instrumental Variables Regression with an Application to Genomics Data
Jiarui Lu, University of Pennsylvania; Hongzhe Li, University of Pennsylvania
10:35 AM

Single-Cell RNA Sequencing: Dropout Imputation and Normalization with Spike-In Genes
Nicholas Lytal, University of Arizona; Di Ran, University of Arizona; Lingling An, University of Arizona
10:50 AM

Spline Smoothing in Dendrochronology
Nicholas Bussberg, Indiana University; Justin Maxwell, Indiana University; Scott Robeson, Indiana University; Chunfeng Huang, Indiana University
11:00 AM

WPSVM for Spatial Point Processes Directed by Gaussian Random Fields
Subha Datta, New Jersey Institute of Technology
11:05 AM

Your Dreams May Come True with MTP2
Caroline Uhler, Massachusetts Institute of Technology
11:15 AM

Further Improvements in Local FDR Based Grouped Hypotheses Testing
Shinjini Nandi, Temple University; SANAT SARKAR, Temple University
2:05 PM

Deep Neural Network Model for Predicting Gene Activity Using Three-Dimensional Structures of Chemical Compounds
Pingzhao Hu, University of Manitoba; Md. Mohaiminul Islam, University of Manitoba; Kevin Jeffers, University of Manitoba; Andrew M Hogan , University of Manitoba; Rebecca Davis, University of Manitoba; Silvia Cardona, University of Manitoba
2:05 PM

A Bayesian Hierarchical Framework for Pathway Analysis in Genome-Wide Association Studies
Swati Biswas, University of Texas at Dallas; Lei Zhang, University of Texas at Dallas; Pankaj Choudhary, University of Texas at Dallas
2:05 PM

Estimating Survey Attrition Phases Using Change-Point Models
Camille Hochheimer, Virginia Commonwealth University; Roy T Sabo, Virginia Commonwealth University; Alex H Krist, Virginia Commonwealth University
2:05 PM

An Application of 2-In-1 Adaptive Phase 2/3 Design for Expedited Oncology Drug Development
Xinqun (Maggie) Chen, Merck & Co., Inc.; Linda Sun, Merck & Co., Inc.; Cong Chen, Merck & Co.
2:05 PM

A Meta-Analysis to Indirectly Compare Experimental Drugs Across Multiple Indications Using a Bayesian Hierarchical Model
Ji Lin, Eli Lilly; Jingyi Liu, Eli Lilly; Zachary Thomas, Eli Lilly; Yumin Zhao, Eli Lilly & Co.; Mythili Koneru, Eli Lilly
2:05 PM

Addressing Sexual Misconduct in the Statistics Community
Leslie McClure, Drexel University; Kristian Lum, Human Rights Data Analysis Group; Kerrie Mengersen, Queensland University of Technology; Lance Waller, Emory University; Dianne Cook, Monash University; Emma Benn, Icahn School of Medicine at Mount Sinai; Brian Millen, Eli Lilly
2:05 PM

Extrapolation in Pediatric Drug Development: an Evolving Science
Yeruk Mulugeta, FDA; Lynne Yao, US FDA
2:05 PM

Census Efforts to Reduce the Undercount of Young Children
Gina Walejko, U.S. Census Bureau; Scott Konicki, U.S. Census Bureau
2:10 PM

Critical Steps for Composite Endpoint Analysis
Jerry J. Li, Merck & Co., Inc.
2:20 PM

Spatial Modeling of Rainfall Accumulated Over Short Periods of Time
Victor De Oliveira, The University of Texas at San Antonio; Binbin Wang, The University of Texas at San Antonio; Eric V. Slud, University of Maryland--College Park
2:20 PM

Exact Inference in Functional Regression: Estimating Hydrological Controls on Ecosystem Dynamics in an Antarctic Lake
Radu Herbei, The Ohio State University; Corey J. Smith, The Ohio State University
2:25 PM

Using Data to Drive Curriculum Development
Chester Ivan Ismay, DataCamp
2:25 PM

Estimation of Parameters of a Mixture of Two Exponential Distributions
Trijya Singh
2:35 PM

Characterising for Sensitivity Analyzes the Participant Attrition in a Childhood Cohort with Large Initial Drop-Out
Petr Otahal, Menzies Institute for Medical Research University of Tasmania; Leigh Blizzard, Menzies Institute of Medical Research, University of Tasmania; David W Hosmer, University of Massachusetts; Jim Stankovich, School of Medicine, University of Tasmania; Alison Venn, Menzies Institute for Medical Research University of Tasmania
2:35 PM

Statistical Considerations for Bridging Studies in Precision Medicine Programs with Drug-Device Co-Development
Shunguang Wang, Novartis Analytics; Meijuan Li, FDA; Xiaohong Li, Novartis Analytics; Jincao Wu, CDRH/US. Food and Drug Adminstration; Robinson Douglas, Novartis Pharmaceuticals
3:15 PM

Multiple Imputation Methods Addressing Planned Missingness in a Multi-Phase Survey
Irina Bondarenko, University of Michigan; Yun Li, University of Michigan; Paul Imbriano, University of Michigan
3:20 PM

Tuesday, 07/31/2018

Becoming a Stats Star: How to Step Up and Overcome Your Fears to Lead Fruitful Collaborations
Tamar Sofer, Brigham and Women's Hospital

Use of Modified Risk Function in Drug Intervention Planning
Myung Shin Sim, UCLA

A Bayesian Adaptive Design in Cancer Phase I/II Trials with Drug Combinations Using Escalation with Overdose Control (EWOC) and Adaptive Randomization
Sungjin Kim, Cedars-Sinai Medical Center; José L. Jiménez, Politecnico di Torino; Mourad Tighiouart, Cedars-Sinai Medical Center

Measuring the Percentage of Smoothness in the Trend of a Univariate Time Series: An Application to a Time Series of Mexico's GDP
Daniela Cortés Toto, Universidad De Las Américas Puebla (UDLAP); Víctor M. Guerrero, Instituto Tecnológico Autónomo de México (ITAM); Hortensia J. Reyes Cervantes, Benemérita Universidad Autónoma de Puebla (BUAP)

Bayesian Methods in Real-World Evidence for Medicinal Product Development: Can Prior Distributions Provide a Platform for Creating Real-World Evidence?
John Loewy, Dataforethought

Seeking Optimal Oral Cancer Drug Combinations
Ricardo Palafox, CSU Fullerton; Jessica Jaynes , CSU Fullerton

An Ensemble RNA-Seq Differential Analysis Method for False Discovery Rate Control
Dongmei Li, University of Rochester; Ananta Paine, University of Rochester; Timothy D. Dye, University of Rochester

A Two-Stage Microbial Association Mapping Framework with Advanced FDR Control
Jiyuan Hu, New York University School of Medicine; Huilin Li, New York University; Hyunwook Koh, NYU langone medical center; Linchen He, NYU langone medical center; Martin Blaser, New York University School of Medicine

The Home Run Spike of MLB 2017: Drop in Quality of Pitch (QOP) Is a Missing Factor
Jason Wilson, Biola University

Generalized Estimating Equations for Social Network Data
Miles Ott, Smith College; Bjorn Westgard, HealthPartners; Brian Martinson, HealthPartners; Michael Maciosek, HealthPartners

Census Efforts to Reduce the Undercount of Young Children
Gina Walejko, U.S. Census Bureau; Scott Konicki, U.S. Census Bureau

Sampling from Twitter: Can a Probability Sample Be Drawn to Target Hard to Reach Populations?
Marcus Berzofsky, RTI International; Tasseli McKay, RTI International; Patrick Hsieh, RTI International; Amanda Smith, RTI Internatinal; Natasha Latzman, RTI International

Addressing Challenges in an International Study with Propensity Scores: a Case Study from Indonesia
Marissa Gargano, RTI International; Susan Edwards, RTI International

MLB Rule IV Draft: Valuing Draft Pick Slots
Anthony Cacchione, City College of New York

A Probabilistic Linkage Approach for Combining VA and State Prescription Drug Databases for Evaluating Veterans' Receipt of Long-Term Opioid Therapy Across Multiple Systems
Larry Cook, University of Utah; Tess A Gilbert, HSR&D Center to Improve Veteran Involvement in Care ; Kathleen F Carlson, HSR&D Center to Improve Veteran Involvement in Care

Multiple Imputation Methods Addressing Planned Missingness in a Multi-Phase Survey
Irina Bondarenko, University of Michigan; Yun Li, University of Michigan; Paul Imbriano, University of Michigan

Sensitivity to Infusion and Blood Draw Time Recording Errors in Pharmacokinetic Modeling
Hannah Weeks, Vanderbilt University; Matthew S Shotwell, Vanderbilt University

Re-Engineered Address Canvassing for the 2018 End-to-End Census Test
Matthew Herbstritt

Data-Driven Biomarker Evaluation in Adaptive Designs Using SIDES
Ilya Lipkovich, IQVIA; Alex Dmitrienko, Mediana Inc
8:35 AM

Addressing Challenges in an International Study with Propensity Scores: a Case Study from Indonesia
Marissa Gargano, RTI International; Susan Edwards, RTI International
8:45 AM

Optimal Approach for Addressing Multiple Stakeholders' Requirements in Drug Development
Zoran Antonijevic
8:55 AM

On the Use of Raking to Improve Regression Calibration: A Flexible Method to Address Error-Induced Bias Efficiently
Eric Oh, University of Pennsylvania; Pamela A Shaw, University of Pennsylvania
9:00 AM

WITHDRAWN: Combining Biomarkers to Improve Classification Accuracy Under Heterogeneous Transformations
Aiyi Liu, BBB/DIPHR/NICHD; Wei Zhang, BBB/DIPHR/NICHD
9:15 AM

Benefit Cost Ratio Analysis in Oncology Drug Development: Single Arm Vs RCT
Thomas Jemielita, Merck & Co.; Cong Chen, Merck & Co.
9:15 AM

Specific Safety Monitoring Tools and How This Will Benefit Drug Safety
James Buchanan, Covilance LLC
9:15 AM

A Statistical Approach Based on NHANES 1963-2016 Data to Track Severe Obesity in Children Aged 2-20 Years
Rong Wei, National Center for Health Statistics; David S Freedman, Division of Nutrition, Physical Activity and Obesity, CDC
9:20 AM

Using Survival Analysis to Address Attrition and Vacancy Rates at the Food Safety and Inspection Service
Sarah McMillan, Food Safety and Inspection Service / USDA; Anna Frey, Food Safety and Inspection Service / USDA
9:20 AM

Projection-Based Inference for High-Dimensional Linear Models
Sangyoon Yi, Texas A&M Univ; Xianyang Zhang, Texas A&M University
9:20 AM

A Multi-Step Classifier Addressing Cohort Heterogeneity Improves Performance of Prognostic Biomarkers in Three Cancer Types
Ellis Patrick, University of Sydney; Samuel Mueller, The University of Sydney; Jean Yee Hwa Yang, University of Sydney, Australia
9:35 AM

Re-Engineered Address Canvassing for the 2018 End-to-End Census Test
Matthew Herbstritt
9:45 AM

Statistical Leadership in Clinical Trials: Opportunities from the Draft Estimand Guidance
Jonathan Siegel, Bayer HealthCare Pharmaceuticals Inc.
9:50 AM

Sensitivity to Infusion and Blood Draw Time Recording Errors in Pharmacokinetic Modeling
Hannah Weeks, Vanderbilt University; Matthew S Shotwell, Vanderbilt University
9:55 AM

Big Data Analysis Points Toward New Cancer Therapeutic Discovery Approach
Bin Chen, UCSF
10:35 AM

The Relationship Between Moderate to Vigorous Physical Activity and Metabolic Syndrome: a Bayesian Measurement Error Approach
Daniel Ries, Sandia National Laboratories; Alicia Carriquiry, Iowa State University
10:35 AM

Data-Driven Modeling and Forecast of Noisy Nonlinear Dynamics
Kyongmin Yeo, IBM T.J. Watson Research Center; Youngdeok Hwang, Sungkyunkwan University; Eun Kyung Lee, IBM T.J. Watson Research Center
10:35 AM

Generalized Estimating Equations for Social Network Data
Miles Ott, Smith College; Bjorn Westgard, HealthPartners; Brian Martinson, HealthPartners; Michael Maciosek, HealthPartners
10:55 AM

Assessment of Biomarkers and Surrogate Endpoints in Drug Development
Ivan Chan, AbbVie Inc; Shu-Chih Su, Merck Research Labs
10:55 AM

Functional Graphical Models for Analyzing Interactions Between Animals
Jan Gertheiss, Clausthal University of Technology
11:15 AM

Estimation of the Dose-Response Curve in the Presence of Outcome Driven Dose Titrations
Zhuqing Liu, Eli Lilly; Yongming Qu, Eli Lilly and Company
11:20 AM

DREAM Challenges: a Community Framework for Benchmarking Reproducible Biomedical Models
Justin Guinney, Sage Bionetworks
11:35 AM

The Large-Scale Universe: a 3D Map via the Lya Forest of BOSS DR12 Quasars
Collin Eubanks, Carnegie Mellon University
11:35 AM

The Home Run Spike of MLB 2017: Drop in Quality of Pitch (QOP) Is a Missing Factor
Jason Wilson, Biola University
11:35 AM

Statistical Graphics in Drug Development: Dose-Finding to Dossier Submission
Suddhasatta Acharyya, Novartis pharmaceuticals corporation
11:50 AM

MLB Rule IV Draft: Valuing Draft Pick Slots
Anthony Cacchione, City College of New York
12:00 PM

Nonparametric Inference on L\'Evy Measures of L\'Evy-Driven Ornstein-Uhlenbeck Processes
Daisuke Kurisu
12:05 PM

Application of Bayesian Analysis on Blood Lead Level Data for Children
Shailendra Banerjee, Centers for Disease Control
12:05 PM

Harnessing the Power of the Web via R Clients for Web APIs
Lucy D'Agostino McGowan, Vanderbilt University
2:05 PM

Predicting Panel Drop-Outs with Machine Learning
Christoph Kern, University of Mannheim
2:20 PM

Dose Finding Model Selection in Oncology Combination Therapy
Lixia Pei, Janssen Pharmaceuticals ; Yichen Guo, Harvard University; Kevin Liu, Janssen Pharmaceuticals
2:20 PM

Decision-Adjusted Predictive Modeling Approach for Driver Risk Assessment
Huiying Mao, Virginia Tech / VTTI; Feng Guo, Virginia Tech; Xinwei Deng, Virginia Tech
2:35 PM

Causal Inference for the Risk of Cellphone Use While Driving
Danni Lu, Virginia Tech; Feng Guo, Virginia Tech; Fan Li, Duke University
2:50 PM

Reducing Accelerometer Data in Instrumented Vehicles
Michael Owen Bishop, University of Iowa College of Public Health; Jeffrey D Dawson, University of Iowa College of Public Health; Jennifer Merickel, University of Nebraska Medical Center; Matthew Rizzo, University of Nebraska Medical Center
3:05 PM

Prescription Medications and Traffic Fatalities in Older Drivers: The Influence of Vehicle Characteristics, Driving Conditions and Roadway Geometry
Michael Singleton, University of Kentucky; Larry Cook, University of Utah
3:20 PM

Wednesday, 08/01/2018

Ggdag and Confoundr: R Packages for Causal Inference with DAGs and Data
Malcolm Barrett

Statistical Approaches to Assess Early Life Exposure to Complex Mixtures and Associations with Latent Patterns of Neurodevelopmental Trajectories
Shelley H. Liu, Icahn School of Medicine at Mount Sinai; Brent A. Coull, Harvard TH Chan School of Public Health; Robert Wright, Icahn School of Medicine at Mount Sinai

A Novel Blind Start Study Design to Investigate Vestronidase Alfa for Mucopolysaccharidosis VII, an Ultra-Rare Genetic Disease
Wenjie Song, Ultragenyx Pharmaceutical Inc; Chao-Yin Chen, Ultragenyx Pharmaceutical Inc; Christine Haller, Ultragenyx Pharmaceutical Inc; Emil Kakkis, Ultragenyx Pharmaceutical Inc

Exposure-Response Analysis with Random Forest
Zifang Guo, Merck; Thomas Jemielita, Merck & Co.; John Kang, Merck

A Data-Driven Approach for Assessing the Risk of Dengue Transmission Using High-Resolution Weather Data
Chathurika Hettiarachchige, IBM Research - Australia; Roslyn Hickson, IBM Research - Australia; Stefan von Cavallar, IBM Research - Australia; Timothy Lynar, IBM Research - Australia; Manoj Gambhir, IBM Research - Australia

Impostor Syndrome
Rebecca W Doerge, Carnegie Mellon University ; Alicia Carriquiry, Iowa State University; Sastry Pantula, Oregon State University
8:35 AM

Modeling Covariance Structure for Longitudinal Data
Annie Qu, University of Illinois at Urbana-Champaign
8:35 AM

Model Driving Risk Through Naturalistic Driving Studies
Feng Guo, Virginia Tech
8:35 AM

General Covering Principle: a New Approach to Address Multiplicity in Hypothesis Testing
Huajiang Li, Avanir Pharmaceuticals; Hong Zhou, Arkansas State University
8:50 AM

A Reflection of the Statistical Assessment for Analytical Similarity and Beyond ----Are We Addressing the Right Question?
Aili Cheng, Pfizer
9:35 AM

Compositional Knockoff Filter for FDR Control in Microbiome Regression Analysis
Arun Srinivasan, Pennsylvania State Univ; Lingzhou Xue, Penn State University and National Institute of Statistical Sciences; Xiang Zhan, Pennsylvania State University
9:35 AM

EXTENDED SENSITIVITY ANALYSIS for HETEROGENEOUS UNMEASURED CONFOUNDING with an APPLICATION to SIBLING STUDIES of RETURNS to EDUCATION
Raiden Hasegawa, The Wharton School, University of Pennsylvania; Colin Fogarty, Massachusetts Institute of Technology
9:35 AM

Nonstationary Flood Frequency Analysis: a Mixed and Pooled Approach
Philip Yates, DePaul University; John Grego, University of South Carolina
9:50 AM

Exposure-Response Analysis with Random Forest
Zifang Guo, Merck; Thomas Jemielita, Merck & Co.; John Kang, Merck
10:00 AM

Addressing Missing Accelerometer Data with Functional Data Analysis (FDA)
Patrick Hilden; Joseph Schwartz, Columbia University; Jeff Goldsmith, Columbia University
10:05 AM

Calibrating Big Data for Population Inference: Applying Quasi-Randomization Approach to Naturalistic Driving Data Using Bayesian Additive Regression Trees
Ali Rafei, University of Michigan; Michael Elliott, University of Michigan; Carol A.C. Flannagan, University of Michigan, Transport Research Institute
10:35 AM

Novel Model-Assisted Designs for Phase I Drug Combination Trials
Ruitao Lin, MD Anderson Cancer Center
10:35 AM

Sparse Quadratic Classification Rules via Linear Dimension Reduction
Tianying Wang, Texas A & M University; Irina Gaynanova, Texas A&M Univeristy
10:35 AM

A Comparison of Statistical Models for Recurrent Events with Applications to Hospitalization and Death Events
Jihong Chen, Alnylam Pharmaceuticals; Tim Lin, Alnylam Pharmaceuticals; Matthew T. White, Alnylam Pharmaceuticals; Christine Powell, Alnylam Pharmaceuticals; Andrew Strahs, Alnylam Pharmaceuticals
11:05 AM

Improving Dose-Finding for Early Oncology Trials with Monotherapy and Combination Therapy
Zhen Zeng, Merck & Co.; Meihua Wang, Merck & Co.; Victoria Plamadeala Johnson, Merck & Co.; Cong Chen, Merck & Co.
11:15 AM

On Randomized Controlled Trials with Integrated Real World Evidence for Drug Development in Rare Diseases
Qing Liu, Amicus Therapeutics, Inc
11:15 AM

Addressing the Issue of Subject Confusion Due to the Use of Two Visual Analog Scales in Human Abuse Potential Studies
Ling Chen, CDER, FDA
11:20 AM

Bayes in Drug Development for Rare Diseases
John Scott, FDA
11:35 AM

Integrative Statistical Learning with Real World Healthcare Data: Towards a Data Driven Suicide Prevention Framework
Kun Chen, University of Connecticut
11:55 AM

Substate Small Area Estimates Using Data from the 2014-2016 National Surveys on Drug Use and Health (NSDUHs)
Neeraja Sathe, RTI International; Matthew Williams, SAMHSA/CBHSQ; Kathy Spagnola, RTI International; Akhil Vaish, RTI International
2:05 PM

Optimal Quadratic Estimators Using Fourier Transform in the Central Subspaces
Jiaying Weng, University of Kentucky; Xiangrong Yin, University of Kentucky
2:20 PM

Small Area Population Models: Estimating the Number of Children in School Districts
Jerry Maples, U.S. Census Bureau; Patrick Joyce, U.S. Census Bureau
2:20 PM

Combining (Epi)Genetic and Imaging Data with Multivariate Data-Driven Models
Vince Calhoun, The Mind Research Network & The University of New Mexico
2:30 PM

On Post Dimension Reduction Statistical Inference
Kyongwon Kim, The Pennsylvania State University; Bing Li, The Pennsylvania State University
2:35 PM

Comparison of NSDUH Population Percentages from the United States, Census Regions, States, and the District of Columbia
Kathy Spagnola, RTI International; Matthew Williams, SAMHSA/CBHSQ; Akhil Vaish, RTI International; Neeraja Sathe, RTI International
2:35 PM

An Additive-Multiplicative Mean Model for Panel Count Data with Dependent Observation and Dropout Processes
Yang Li, UNC-Charlotte; Guanglei Yu, Eli Lilly and Company; Liang Zhu, University of Texas Health Science Center at Houston; Hui Zhao, Central China Normal University; (Tony) Jianguo Sun, University of Missouri; Leslie Robison, St. Jude Children's Research Hospital
3:20 PM

Hydraulic Fluids: a Case Study of a Split-Plot Experiment
Jennifer Kensler, Shell
3:35 PM

Thursday, 08/02/2018

Foundation or Backdrop? The Role of Statisticians in Academic Data Science Initiatives
Patrick J Wolfe, Purdue University; Jennifer L Hill, New York University; David Madigan, Columbia University; Edoardo M Airoldi , Harvard University; Tian Zheng, Columbia University
8:35 AM

Power vs. Responsibility: Naturalistic Driving Data Use Cases
Miguel A. Perez, Virginia Tech
8:35 AM

Relationship Between Positive Responses to Child-Specific Probes on the 2010 Census Questionnaire and 2010 Census Coverage Measurement Nonmatching Young Children
Mary Mulry, U.S. Census Bureau
8:35 AM

The Effects of Address Coverage Enhancement on Estimates from a Study using an ABS Frame
Michael Jones, Westat; J. Michael Brick, Westat; Andrea Piesse, Westat
8:50 AM

A Data-Driven Approach to Source-Receptor Mapping of Power Plant Emissions to Exposed Populations
Kevin Cummiskey, United States Military Academy; Christine Choirat, Harvard T.H. Chan School of Public Health; Chanmin Kim, Boston University School of Public Health; Lucas Henneman, Harvard T.H. Chan School of Public Health; Corwin Zigler, Harvard T.H. Chan School of Public Health
8:50 AM

Balancing Participant Privacy Protection with Data Utility in Large Scale Transportation Studies
Suzie Lee, VTTI
8:55 AM

Emulating Satellite Drag from Large Simulation Experiments
Furong Sun, Virginia Tech; Robert Gramacy, Virginia Tech; Benjamin Haaland, Population Health Sciences, University of Utah; Earl Christopher Lawrence, Los Alamos National Laboratory; Andrew Walker, Space Science and Applications, Los Alamos National Laboratory
9:05 AM

Switching from Field Enumeration to an ABS Frame: The Effect on Coverage Bias
Ashley Amaya, RTI International; Matthew Williams, SAMHSA/CBHSQ; Devon Cribb, RTI International; Rachel Harter, RTI International; Katherine B Morton, RTI International
9:05 AM

Visual Analytics to Assess Reasonable Possibility: Using DILI as an Example
Kefei Zhou, Theravance Biopharma; Melvin Munsaka, AbbVie, Inc.; Krishan P. Singh, GlaxoSmithKline
9:15 AM

SHRP 2 Naturalistic Driving Study Data: Potential Framework for Participant Disclosure Risk Assessment and Management
Christian Richard, Battelle; Filmon Habtemichael, Battelle; James Brown, Battelle
9:35 AM

Statistical Challenges and Opportunities in Drug Development for Rare Diseases
Guowen Sun, BioMarin; Keith Gregg, BioMarin; Peter Slasor, BioMarin; Chito Hernandez, BioMarin Pharmaceutical Inc.
9:50 AM

Post-Stratification in Network Driven Sampling
Yilin Zhang, University of Wisconsin-Madison; Sebastien Roch, University of Wisconsin-Madison; Karl Rohe, University of Wisconsin-Madison
9:55 AM

Global Mean-Field Variational Bayes for Density Regression
Tommaso Rigon, Bocconi University; Daniele Durante, Bocconi University
9:55 AM

How Human Behavior Drives Data Science---and How We Know Almost Nothing About It
Jeffrey Leek, Johns Hopkins Bloomberg School of Public Health
10:35 AM

Bayesian Adaptive Dosing: Tailoring Patient Exposure Reduces Therapeutic Failures
Diane Mould, Projections Research, Inc.
10:35 AM

A Bayesian Adaptive Phase 1/2 Design of Cisplatin and Cabazitaxel in Prostate Cancer with Visceral Metastasis
Mourad Tighiouart, Cedars-Sinai Medical Center
10:35 AM

MDR with P Risk Scores Per Person with Application to Alzheimer's Disease Data
Ye Li, University of Kentucky; Richard Charnigo, University of Kentucky
10:50 AM

The pbdR Project: Distributed Computing with R
Wei-Chen Chen, FDA/CDRH; Drew Schmidt, ORNL; George Ostrouchov, Oak Ridge National Laboratory
11:15 AM

Bayesian Network Meta-Regression Models Using Heavy-Tailed Multivariate Random Effects with Covariate-Dependent Variances
Ming-Hui Chen, University of Connecticut; Hao Li, University of Connecticut; Joseph G Ibrahim, University of North Carolina Chapel Hill; Sung Duk Kim, National Cancer Institute; Arvind K. Shah, MRL, Merck & Co., Inc.; Jianxin Lin, MRL, Merck & Co., Inc.; Andrew M. Tershakovec, MRL, Merck & Co., Inc.
11:15 AM

A Smooth Simultaneous Confidence Band for Correlation Curve
Yuanyuan Zhang, Tsinghua University; Lijian Yang, Tsinghua University
11:35 AM

Methodological Considerations for the Analysis of Relative Treatment Effects in Multi-Drug-Resistant Tuberculosis from Fused Observational Studies
Mireille Schnitzer, University of Montreal; Andrea Benedetti, Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre; Guanbo Wang, McGill University; Arman Alam Siddique, McMaster University; Asma Bahamyirou, Université de Montréal
11:35 AM

Trends in Hepatitis B Birth Dose Vaccination Coverage Disparities by Birth Year Cohort for Children in the United States, 2005-2014
Zhen Zhao, CDC; Holly A Hill, CDC
11:50 AM

JSM 2018 Online Program

Keyword Search

American Statistical Association